Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Merck's Two-Drug HIV Regimen Challenges Industry Standards Following Positive Phase 3 Results
Via MarketMinute
Topics Intellectual Property
Tickers ARM GILD GSK MRK
Exposures Intellectual Property Product Safety
News headline image
Custom vs. Standard LASIK in Portland, Oregon: New Resource from Tersigni Vision Helps Patients Understand Key Differences
Via Press Advantage
Exposures Product Safety
News headline image
FDA Commissioner Refers To Rare Disease Drug With Associated Morbidity: Analysts Are Divided If Makary Meant Regenxbio Or Uniqure’s Experimental Therapy ↗
Via Stocktwits
Tickers QURE RGNX
Exposures Product Safety
News headline image
Uniqure Plummets As FDA's Marty Makary Disparages Rejected Rare Disease Drug ↗
Via Investor's Business Daily
Exposures Product Safety
News headline image
Pfizer Secures Full FDA Approval for BRAFTOVI in First-Line Colorectal Cancer, Bolstering Oncology Growth Strategy
Via MarketMinute
Topics Economy Intellectual Property
Tickers AZN BMY LLY MRK NVS PFE
Exposures COVID-19 Intellectual Property Interest Rates
News headline image
Corcept Therapeutics (NASDAQ: CORT) Investors Who Have Suffered Losses - Contact Kaplan Fox before April 21, 2026 Lead Plaintiff Deadline
Via TheNewswire.com
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
Corcept Therapeutics (NASDAQ: CORT) Investors Who Have Suffered Losses - Contact Kaplan Fox before April 21, 2026 Lead Plaintiff Deadline
Via NewMediaWire
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
Hims & Hers at the Crossroads: Navigating the ‘Regulatory Winter’ of 2026
Via Finterra
Topics Economy Initial Public Offering Intellectual Property
Tickers AMZN HIMS LLY NVO
Exposures Financial Intellectual Property Interest Rates
News headline image
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline
Via NewMediaWire
Topics Fraud Lawsuit
Tickers DOCS QURE
Exposures Financial Legal Product Safety
News headline image
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers DOCS QURE
Exposures Financial Legal Product Safety
News headline image
The Moonshot Medicine: United Therapeutics Surges on Record Earnings and TreSMI Breakthrough
Via Finterra
Topics Earnings Economy Intellectual Property
Tickers BLK LQDA MRK UTHR
Exposures Financial Intellectual Property Interest Rates
News headline image
The Celsius Surge: Why the Market is Re-Energized by CELH’s Adjusted Earnings Beat
Via Finterra
Topics Earnings Economy Lawsuit
Tickers CELH GS MNST MS PEP
Exposures Ethanol Financial Interest Rates
News headline image
The Pivot to Growth: Viatris (VTRS) Enters Phase 2 with 2026 Dividend and Capital Allocation Strategy
Via Finterra
Topics Economy
Tickers JPM OGN PFE TEVA UBS VTRS
Exposures Interest Rates Product Safety Supply Chain
News headline image
Argenx (ARGX) 2026 Feature: The Anatomy of a Biotech Powerhouse Transitioning to Profitability
Via Finterra
Topics Earnings Economy Intellectual Property
Tickers ARGX BLK FIS GS IMVT JNJ
Exposures Financial Intellectual Property Interest Rates
News headline image
United Therapeutics (UTHR) Deep Dive: Strong Q4 and the ‘Inhalation Evolution’
Via Finterra
Topics Artificial Intelligence Economy Intellectual Property
Tickers ARM BLK GS GSK JPM LQDA
Exposures Artificial Intelligence Intellectual Property Interest Rates
News headline image
Rhythm Pharma (RYTM) Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers RYTM
Exposures Financial Product Safety
News headline image
Got $10,000? This Under‑the‑Radar Medical Device Giant Could Be a Millionaire Maker by 2036. ↗
Via The Motley Fool
Tickers ISRG MDT
Exposures Product Safety
News headline image
ImmunityBio Investors Rally Behind Cancer Trial Milestone ↗
Via Benzinga
Exposures Product Safety
News headline image
Hims & Hers: The Telehealth Growth Story Younger Investors Can't Afford to Ignore ↗
Via The Motley Fool
Tickers HIMS LLY NVO
Exposures Product Safety
News headline image
Stocks Under $5 to Watch Now: LRMR, RXRX, NDRA, BTQ, CDIO Watch Now!
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
Tickers BTQ LRMR MSFT NDRA RXRX
Exposures Artificial Intelligence Intellectual Property Product Safety
News headline image
Morfose Business Developer Samet Metin Karaman Focuses on Evidence-Driven Growth for Beauty Brands
Via Press Release Distribution Service
Topics Economy
Tickers AMZN
Exposures Product Safety Supply Chain
News headline image
Larimar Prices $100M Stock Sale After Record Rally Fueled By FDA Breakthrough Tag For Protein Replacement Therapy ↗
Via Stocktwits
Tickers LRMR
Exposures Product Safety
News headline image
Arcutis (ARQT) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers ARQT
Exposures Financial Product Safety
News headline image
ACADIA (ACAD) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers ACAD
Exposures Financial Product Safety
News headline image
Revolution Medicines (RVMD) Earnings Transcript ↗
Via The Motley Fool
Tickers RVMD TN
Exposures Product Safety
News headline image
Mirum (MIRM) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers MIRM
Exposures Financial Product Safety
News headline image
Gilead’s Twice-Yearly HIV Breakthrough: A Paradigm Shift in Global Prevention and Market Dominance
Via MarketMinute
Topics Intellectual Property
Tickers GILD GSK MRK PFE
Exposures Intellectual Property Product Safety
News headline image
Eli Lilly Bolsters Genetic Medicine Portfolio with $2.4 Billion Acquisition of Orna Therapeutics
Via MarketMinute
Topics Intellectual Property
Tickers ABBV AZN BMY GILD LLY MRK
Exposures Intellectual Property Product Safety
News headline image
Disc Medicine Stock Is Swinging, but This Fund's New $52 Million Bet Shows Conviction ↗
Via The Motley Fool
Topics Regulatory Compliance
Tickers GPCR IRON KYMR MLTX OLMA RVMD
Exposures Legal Product Safety Regulatory
News headline image
Disc Medicine Lands New $20 Million Investment as FDA Sets Up Potential Q4 Catalyst ↗
Via The Motley Fool
Topics Regulatory Compliance
Tickers AMLX APGE IRON RAPT ZURA
Exposures Legal Product Safety Regulatory
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.